Apple’s stock split history: Everything you need to know
Apple Inc. (AAPL) has executed five stock splits since its 1980 IPO, with the most recent being a 4-for-1 split…
Tag: biotech stocks
Cantor Fitzgerald Boosts Belite Bio Price Target to $266 on Stronger Pricing Outlook for Tinlarebant
Cantor Fitzgerald has significantly increased its price target on Belite Bio (NASDAQ: BLTE) to $266 from $200, while maintaining an…
Protagonist Therapeutics Director Sells 20,000 Shares Amid Strong Stock Performance
In a recent insider transaction, Protagonist Therapeutics director William D. Waddill exercised stock options and sold 20,000 shares of PTGX…